Loading...
Powered By
8 items
2025-06-10
On June 9, 2025, Fuva Brain Limited closed the transaction.
2025-05-31
Fuva Brain Limited announced that they will report Q1, 2026 results on Aug 14, 2025
2025-05-24
Fuva Brain Limited expected to report Q1 2026 results on August 8, 2025. This event was calculated by S&P Global (Created on May 24, 2025).
2025-05-15
Fuva Brain Limited, Annual General Meeting, Jun 24, 2025.
2025-03-04
Fuva Brain Limited announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 15, 2025
2024-11-30
Fuva Brain Limited announced that they will report Q3, 2025 results on Feb 14, 2025
2024-10-03
Fuva Brain Limited (TSE:3927) agreed to acquire 51.40% stake in ichi R Inc. for ¥360 million on September 30, 2024. For the period ending February 29, 2024, ichi R Inc. reported total revenue of ¥501 million, EBIT of ¥49 million and net income of ¥36 million. As of February 29, 2024, ichi R Inc. reported total assets of ¥246 million and total common equity of ¥168 million. The expected completion of the transaction is October 15, 2024.
2024-10-02
Fuva Brain Limited (TSE:3927) acquired 51.70% stake in ARPEGGIO inc. from Takashi Tsuzuki and Maison Marc Co., Ltd. for approximately ¥100 million on September 30, 2024. A cash consideration of ¥103 million will be paid by Fuva Brain Limited. As part of consideration, ¥103 million is paid towards common equity of ARPEGGIO inc. Fuva Brain Limited (TSE:3927) completed the acquisition of 51.70% stake in ARPEGGIO inc. from Takashi Tsuzuki and Maison Marc Co., Ltd. on September 30, 2024.
2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | |
|---|---|---|---|---|---|---|---|---|
Total Revenues | 4,720 | 4,373 | 3,978 | 3,486 | 3,289 | 3,075 | 2,899 | 2,687 |
Pretax Income Excl.Unusual Items | 194 | 164 | 138 | 52 | 33 | 35 | -10 | -7 |
Total Assets | 8,279 | 5,604 | 5,669 | 5,419 | 4,494 | 4,352 | 4,152 | 3,852 |
Total Liabilities | 5,190 | 3,877 | 4,041 | 4,026 | 3,110 | 2,978 | 2,857 | 2,538 |
Cash & Cash Equivalents | 1,786 | 1,522 | 1,504 | 1,267 | 942 | 1,403 | 1,494 | 1,288 |
Total Common Equity | 3,004 | 1,536 | 1,451 | 1,336 | 1,347 | 1,338 | 1,270 | 1,290 |
Book Value Per Share (BVPS) | 562.08 | 287.4 | 271.5 | 255.95 | 258.06 | 257.11 | 244.05 | 247.89 |
Net Change in Cash | 118 | -20 | -11 | -69 | ||||
Capital Expenditure | -12 | -2 | -5 | -9 |
Fuva Brain revealed its financial results for the second quarter of 2025 on August 14, 2025, with revenues of 1.3B yen and net income of 245M yen, indicating a significant 36.3% surge in revenues, with a transition from a loss per share in the same quarter last year to a profit per share in the current quarter. A positive note is that for the 13th consecutive quarter, the company's revenue line has increased compared to last year's corresponding quarter, which demonstrates the company's stability and its ability to grow in the future.
In addition, the EBITDA margin rose sharply from 2.3% in the corresponding quarter last year to 3.91%. It often signifies that the company has raised prices or implemented optimization methods in its activity sectors, leading to an increase in EBITDA margins and, as a result, should support the stock's performance in the future. and it trades at 13.2x times current year's earnings, which is lower than the sector average (P/E 14.3x).